{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T09:21:16Z","timestamp":1787649676164,"version":"build-2736575974"},"reference-count":30,"publisher":"The Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12,1]]},"DOI":"10.1210\/jc.2012-2802","type":"journal-article","created":{"date-parts":[[2012,10,6]],"date-time":"2012-10-06T01:55:49Z","timestamp":1349488549000},"page":"4549-4558","source":"Crossref","is-referenced-by-count":290,"title":["A 2011 Survey of Clinical Practice Patterns in the Management of Graves' Disease"],"prefix":"10.1210","volume":"97","author":[{"given":"Henry B.","family":"Burch","sequence":"first","affiliation":[{"name":"Endocrinology Service, Department of Medicine (H.B.B.), Walter Reed National Military Medical Center, Bethesda, Maryland 20889"},{"name":"Uniformed Services University of the Health Sciences (H.B.B.), Bethesda, Maryland 20814;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth D.","family":"Burman","sequence":"additional","affiliation":[{"name":"Endocrinology Service (K.D.B.), Washington Hospital Center, Washington, D.C. 20010"},{"name":"Georgetown University Medical Center (K.D.B.), Washington, D.C. 20007"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Division of Endocrinology (D.S.C.), The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113253832300_B1","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199206253262603","article-title":"Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.","volume":"326","author":"Tallstedt","year":"1992","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113253832300_B2","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1210\/jc.2009-0747","article-title":"Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131.","volume":"94","author":"Tr\u00e4isk","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113253832300_B3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199801083380201","article-title":"Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.","volume":"338","author":"Bartalena","year":"1998","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113253832300_B4","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/thy.2009.0169","article-title":"The role of propylthiouracil in the management of Graves' disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration.","volume":"19","author":"Bahn","year":"2009","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113253832300_B5","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1210\/jcem-70-6-1518","article-title":"Current trends in the management of Graves' disease.","volume":"70","author":"Solomon","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113253832300_B6","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1089\/thy.2011.0087","article-title":"Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum.","volume":"21","author":"Stagnaro-Green","year":"2011","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113253832300_B7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.7326\/0003-4819-121-8-199410150-00001","article-title":"Discontinuing antithyroid drug therapy before ablation with radioiodine in Graves disease.","volume":"121","author":"Burch","year":"1994","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041113253832300_B8","first-page":"3016","article-title":"The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after 131I ablation for Graves' disease.","volume":"86","author":"Burch","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113253832300_B9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/105072502753522365","article-title":"The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: a randomized clinical trial.","volume":"12","author":"Braga","year":"2002","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113253832300_B10","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/bmj.39114.670150.BE","article-title":"Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials.","volume":"334","author":"Walter","year":"2007","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019041113253832300_B11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0450","article-title":"TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.","volume":"158","author":"Laurberg","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113253832300_B12","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/BF03350047","article-title":"More on smoking habits and Graves' ophthalmopathy.","volume":"12","author":"Bartalena","year":"1989","journal-title":"J Endocrinol invest"},{"key":"key\n\t\t\t\t2019041113253832300_B13","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy.","volume":"362","author":"Bahn","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113253832300_B14","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/thy.2010.0417","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.","volume":"21","author":"Bahn","year":"2011","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113253832300_B15","first-page":"3","article-title":"The management of hyperthyroidism due to Graves' disease in Europe in 1986. Results of an international survey.","volume":"285","author":"Glinoer","year":"1987","journal-title":"Acta Endocrinol Suppl (Copenh)"},{"key":"key\n\t\t\t\t2019041113253832300_B16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1507\/endocrj1954.36.299","article-title":"The management of hyperthyroidism due to Graves' disease in Japan in 1988. The Japan Thyroid Association.","volume":"36","author":"Nagayama","year":"1989","journal-title":"Endocrinol Jpn"},{"key":"key\n\t\t\t\t2019041113253832300_B17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/thy.1997.7.225","article-title":"Case selection and restrictions recommended to patients with hyperthyroidism in South America.","volume":"7","author":"Romaldini","year":"1997","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113253832300_B18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/thy.1997.7.217","article-title":"International differences in approaches to 131I therapy for Graves' disease: case selection and restrictions recommended to patients in Japan, Korea, and China.","volume":"7","author":"Tominaga","year":"1997","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113253832300_B19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/thy.1991.1.129","article-title":"Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States.","volume":"1","author":"Wartofsky","year":"1991","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113253832300_B20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1445-5994.2000.tb00856.x","article-title":"Management of Graves' disease in Australia.","volume":"30","author":"Walsh","year":"2000","journal-title":"Aust NZ J Med"},{"key":"key\n\t\t\t\t2019041113253832300_B21","first-page":"163","article-title":"The management of Graves' disease by Indian thyroidologists.","volume":"6","author":"Mithal","year":"1993","journal-title":"Natl Med J India"},{"key":"key\n\t\t\t\t2019041113253832300_B22","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/pmj.76.896.340","article-title":"Trends in diagnostic and therapeutic criteria in Graves' disease in the last 10 years.","volume":"76","author":"Escobar-Jim\u00e9nez","year":"2000","journal-title":"Postgrad Med J"},{"key":"key\n\t\t\t\t2019041113253832300_B23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.1977.tb01340.x","article-title":"The spectrum of thyroid disease in a community: the Whickham survey.","volume":"7","author":"Tunbridge","year":"1977","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113253832300_B24","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1210\/jc.2009-2752","article-title":"Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008.","volume":"95","author":"Emiliano","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113253832300_B25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1530\/eje.1.02201","article-title":"A questionnaire survey on the management of Graves' orbitopathy in Europe.","volume":"155","author":"Perros","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113253832300_B26","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/cncr.22635","article-title":"Increased cancer incidence after radioiodine treatment for hyperthyroidism.","volume":"109","author":"Metso","year":"2007","journal-title":"Cancer"},{"key":"key\n\t\t\t\t2019041113253832300_B27","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs.","volume":"352","author":"Cooper","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113253832300_B28","article-title":"63 years and 715 days to the \u201cboxed warning\u201d: unmasking of the propylthiouracil problem","author":"Rivkees","year":"2010","journal-title":"Int J Pediatr Endocrinol"},{"key":"key\n\t\t\t\t2019041113253832300_B29","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1210\/jc.2009-2546","article-title":"Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children.","volume":"95","author":"Rivkees","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113253832300_B30","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1056\/NEJMc0809750","article-title":"Ending propylthiouracil-induced liver failure in children.","volume":"360","author":"Rivkees","year":"2009","journal-title":"N Engl J Med"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/97\/12\/4549\/9047282\/jcem4549.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T08:52:50Z","timestamp":1562230370000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/97\/12\/4549\/2536521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,1]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2012-2802","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,1]]}}}